Saffran DC - Search Results

1

Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).

Zhu Q, Zhang M, Rawlings DJ, Vihinen M, Hagemann T, Saffran DC, Kwan SP, Nilsson L, Smith CI, Witte ON, Chen SH, Ochs HD. Zhu Q, et al. Among authors: saffran dc. J Exp Med. 1994 Aug 1;180(2):461-70. doi: 10.1084/jem.180.2.461. J Exp Med. 1994. PMID: 7519238 Free PMC article.

2

Distinctive growth requirements and gene expression patterns distinguish progenitor B cells from pre-B cells.

Faust EA, Saffran DC, Toksoz D, Williams DA, Witte ON. Faust EA, et al. Among authors: saffran dc. J Exp Med. 1993 Apr 1;177(4):915-23. doi: 10.1084/jem.177.4.915. J Exp Med. 1993. PMID: 7681470 Free PMC article.

3

Brief report: a point mutation in the SH2 domain of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia.

Saffran DC, Parolini O, Fitch-Hilgenberg ME, Rawlings DJ, Afar DE, Witte ON, Conley ME. Saffran DC, et al. N Engl J Med. 1994 May 26;330(21):1488-91. doi: 10.1056/NEJM199405263302104. N Engl J Med. 1994. PMID: 8164701 Free article. No abstract available.

4

Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice.

Rawlings DJ, Saffran DC, Tsukada S, Largaespada DA, Grimaldi JC, Cohen L, Mohr RN, Bazan JF, Howard M, Copeland NG, et al. Rawlings DJ, et al. Among authors: saffran dc. Science. 1993 Jul 16;261(5119):358-61. doi: 10.1126/science.8332901. Science. 1993. PMID: 8332901

5

Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia.

Tsukada S, Saffran DC, Rawlings DJ, Parolini O, Allen RC, Klisak I, Sparkes RS, Kubagawa H, Mohandas T, Quan S, et al. Tsukada S, et al. Among authors: saffran dc. Cell. 1993 Jan 29;72(2):279-90. doi: 10.1016/0092-8674(93)90667-f. Cell. 1993. PMID: 8425221

6

Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. 1993.

Tsukada S, Saffran DC, Rawlings DJ, Parolini O, Allen RC, Klisak I, Sparkes RS, Kubagawa H, Mohandas T, Quan S, Belmont JW, Cooper MD, Conley ME, Witte ON. Tsukada S, et al. Among authors: saffran dc. J Immunol. 2012 Apr 1;188(7):2936-47. J Immunol. 2012. PMID: 22442491 No abstract available.

7

Development of btk transgenic mice.

Faust EA, Rawlings DJ, Saffran DC, Witte ON. Faust EA, et al. Among authors: saffran dc. Curr Top Microbiol Immunol. 1995;194:363-70. doi: 10.1007/978-3-642-79275-5_42. Curr Top Microbiol Immunol. 1995. PMID: 7895510 No abstract available.

8

Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene.

Goga A, McLaughlin J, Afar DE, Saffran DC, Witte ON. Goga A, et al. Among authors: saffran dc. Cell. 1995 Sep 22;82(6):981-8. doi: 10.1016/0092-8674(95)90277-5. Cell. 1995. PMID: 7553858 Free article.

9

Establishment of a reproducible culture technique for the selective growth of B-cell progenitors.

Saffran DC, Faust EA, Witte ON. Saffran DC, et al. Curr Top Microbiol Immunol. 1992;182:37-43. doi: 10.1007/978-3-642-77633-5_5. Curr Top Microbiol Immunol. 1992. PMID: 1490376 No abstract available.

10

Target antigens for prostate cancer immunotherapy.

Saffran DC, Reiter RE, Jakobovits A, Witte ON. Saffran DC, et al. Cancer Metastasis Rev. 1999;18(4):437-49. doi: 10.1023/a:1006333222424. Cancer Metastasis Rev. 1999. PMID: 10855787 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters